Literature DB >> 15352331

Differential stimulation of microglial pro-inflammatory cytokines by Acanthamoeba culbertsoni versus Acanthamoeba castellanii.

Francine Marciano-Cabral1, Christina Ludwick, Robyn A Puffenbarger, Guy A Cabral.   

Abstract

Acanthamoeba spp. are opportunistic pathogens that cause granulomatous amebic encephalitis. We compared the highly pathogenic species A. culbertsoni to the relatively less pathogenic species A. castellanii for its capacity to elicit from neonatal rat microglia the gene expression of pro-inflammatory cytokines. Acanthamoeba culbertsoni elicited a robust cytokine gene response by neonatal rat microglia in vitro as compared to A. castellanii. The preponderant cytokine elicited at the mRNA and protein levels was interleukin-1beta. In addition, transmission electron microscopy revealed that microglial cells were capable of phagocytozing A. castellanii. In contrast, A. culbertsoni destroyed microglia. Collectively, these results suggest that a combined action of pro-inflammatory cytokines and destruction of host cells by amebae contribute to the pathology caused by the more pathogenic species.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15352331     DOI: 10.1111/j.1550-7408.2004.tb00398.x

Source DB:  PubMed          Journal:  J Eukaryot Microbiol        ISSN: 1066-5234            Impact factor:   3.346


  2 in total

1.  Acanthamoeba culbertsoni elicits soluble factors that exert anti-microglial cell activity.

Authors:  Jenica L Harrison; Gabriela A Ferreira; Erinn S Raborn; Audrey D Lafrenaye; Francine Marciano-Cabral; Guy A Cabral
Journal:  Infect Immun       Date:  2010-07-06       Impact factor: 3.441

2.  Naegleria fowleri lysate induces strong cytopathic effects and pro-inflammatory cytokine release in rat microglial cells.

Authors:  Yang-Jin Lee; Chang-Eun Park; Jong-Hyun Kim; Hae-Jin Sohn; Jinyoung Lee; Suk-Yul Jung; Ho-Joon Shin
Journal:  Korean J Parasitol       Date:  2011-09-30       Impact factor: 1.341

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.